Biskobing D M, Fan X, Rubin J
Department of Medicine, Emory University School of Medicine and Medical Services, Atlanta, Georgia, USA.
J Bone Miner Res. 1995 Jul;10(7):1025-32. doi: 10.1002/jbmr.5650100706.
To clarify events involved in 1,25(OH)2D3-stimulated osteoclast-like cell (OCLC) formation in primary murine marrow culture, we have characterized kinetics of precursor proliferation and fusion and their dependence on macrophage colony-stimulating factor (MCSF). 3H-thymidine nuclear incorporation in tartrate-resistant acid phosphatase positive multinucleated cells (TRAP+ MNCs) was assessed: 3H-thymidine incorporation was greatest when tracer was added during day 4 or 5, with labeled nuclei in 81% (day 4) and 90% (day 5) of the TRAP+ MNCs counted at the end of day 7. The percentage of total nuclei labeled was highest when 3H-thymidine was dosed on day 4 (58%), decreasing to 2% by day 7. Final TRAP+ MNC numbers were depleted by 80% when treated for 24 h with hydroxyurea on either day 3 or 4; this inhibition dropped to 57% and 12% when hydroxyurea was pulsed during days 5 or 6, respectively. The absence of 1,25(OH)2D3 during days 1-4 caused 70% attenuation of TRAP+ MNC formation; however, exposure to 3H-thymidine during day 4 in this experiment resulted in subsequent labeling of 81% of the TRAP+ MNCs formed, indicating that precursor proliferation occurred in the absence of 1,25(OH)2D3. To demonstrate that proliferation required MCSF, cultures were exposed to a monoclonal anti-MCSF antibody during days 3, 4, 5, 6, or 7. Inhibition of TRAP+ MNC formation was 85% when antibody was added during day 3. Antibody treatment after day 5 had little effect on the OCLC number. Fusion of precursors showed steady progression with OCLCs containing 4.8 +/- 0.3 nuclei at the end of day 4, 8.3 +/- 0.5 nuclei after day 5, 12.0 +/- 1.3 after day 6, and 13.7 +/- 1.5 at the end of day 7. This steady accretion of nuclei was unaffected by doses of MCSF antibody which blocked proliferation. In conclusion, we have shown that OCLCs arise from an MCSF-dependent expansion of the precursor pool occurring during days 3 and 4. Fusion of these precursors, which begins as proliferation diminishes, is able to progress in the presence of anti-MCSF antibody. These results should help refine the analysis of factors affecting proliferation and fusion of osteoclasts in murine marrow culture.
为了阐明在原代小鼠骨髓培养中1,25(OH)₂D₃刺激破骨细胞样细胞(OCLC)形成所涉及的事件,我们已对前体细胞增殖和融合的动力学及其对巨噬细胞集落刺激因子(MCSF)的依赖性进行了表征。评估了3H-胸腺嘧啶核苷在耐酒石酸酸性磷酸酶阳性多核细胞(TRAP⁺ MNCs)中的核掺入情况:当在第4天或第5天添加示踪剂时,3H-胸腺嘧啶核苷掺入量最大,在第7天结束时,81%(第4天)和90%(第5天)的TRAP⁺ MNCs中有标记的细胞核。当在第4天给予3H-胸腺嘧啶核苷时,标记的总细胞核百分比最高(58%),到第7天降至2%。当在第3天或第4天用羟基脲处理24小时时,最终的TRAP⁺ MNC数量减少了80%;当在第5天或第6天脉冲给予羟基脲时,这种抑制分别降至57%和12%。在第1 - 4天缺乏1,25(OH)₂D₃导致TRAP⁺ MNC形成减少70%;然而,在该实验中第4天暴露于3H-胸腺嘧啶核苷导致随后形成的TRAP⁺ MNCs中有81%被标记,这表明前体细胞增殖在没有1,25(OH)₂D₃的情况下发生。为了证明增殖需要MCSF,在第3、4、5、6或7天期间将培养物暴露于单克隆抗MCSF抗体。当在第3天添加抗体时,TRAP⁺ MNC形成的抑制率为85%。第5天后的抗体处理对OCLC数量影响很小。前体细胞的融合显示出稳定进展,在第4天结束时OCLC含有4.8±0.3个细胞核,第5天后为8.3±0.5个细胞核,第6天后为12.0±1.3个细胞核,并在第7天结束时为13.7±1.5个细胞核。这种细胞核的稳定增加不受阻断增殖的MCSF抗体剂量的影响。总之,我们已表明OCLC起源于第3天和第4天期间发生的前体细胞池的MCSF依赖性扩增。这些前体细胞的融合在增殖减少时开始,并且能够在抗MCSF抗体存在的情况下进展。这些结果应有助于完善对影响小鼠骨髓培养中破骨细胞增殖和融合的因素的分析。